Braidwell LP Apellis Pharmaceuticals, Inc. Transaction History
Braidwell LP
- $1.79 Billion
- Q4 2024
A detailed history of Braidwell LP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Braidwell LP holds 2,098,866 shares of APLS stock, worth $57.5 Million. This represents 3.75% of its overall portfolio holdings.
Number of Shares
2,098,866
Previous 3,125,183
32.84%
Holding current value
$57.5 Million
Previous $90.1 Billion
99.93%
% of portfolio
3.75%
Previous 2.55%
Shares
4 transactions
Others Institutions Holding APLS
# of Institutions
304Shares Held
117MCall Options Held
3.03MPut Options Held
1.05M-
Avoro Capital Advisors LLC New York, NY12.2MShares$335 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$326 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$323 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$275 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$264 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.01B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...